Page 1382 - TNFlipTest

8Index MNOP
Toronto Notes 2019
Myasthenia Gravis; N38
Mycology; ID5
Mydriasis; OP30
Myelodysplastic Syndromes; H39 Myeloid Malignancies; H38 Myeloproliferative Neoplasms; H40 Myocardial Disease; C39
Myocardial Perfusion Scanning; MI26 Myocarditis; C39
Myopathies; N40 Myotonic Dystrophy; N41 Myxedema Coma; E28
Nails; D39
Nasal Anatomy; OT3
Nasal Fractures; PL32
Nasal Obstruction; OT8
Nasolacrimal System Defects; OP39 Nausea; OB4
Nausea/Vomiting; G5
Near Drowning; ER48
Neck Mass; OT9, OT31
Necrotizing Enterocolitis; P67 Necrotizing Fasciitis; ID10, PL15 Neglect; P14, P16
Negligence; ELOM11
Nematodes; ID40
Neonatal Hyperbilirubinemia; P65 Neonate Skin Conditions; P70 Neonatology; P59
Neoplasia; GY48
Neoplasms; GS44, R28
Neoplasms of the Head and Neck; OT34 Nephritic Syndrome; P72 Nephroblastoma; P46, U39 Nephrolithiasis; ER42
Nephrotic Syndrome; P73 Neuroanatomy; NS2
Neuroblastoma; P46
Neurocognitive Disorders; PS19 Neurocutaneous Syndromes; P77 Neurodevelopmental Disorders; PS37 Neurofibromatosis; D24
Neurogenic Bladder; U9
Neurogenic Claudication; NS28 Neurological Complaint
Lesion Localization; N2
Neurological Exam; N3
Neurologically Determined Death; NS35 Neuromuscular Junction Diseases; N38 Neuro-Oncology; N29 Neuro-Ophthalmology; N14 Neuropathic Pain; N41 Neuropsychiatric Disorders; NS39
Neuroradiology; MI18
Neurotrauma; NS30
Neutropenia; H9
Neutrophilia; H9
Nightstick Fracture; OR21
Nipple Areolar Complex Reconstruction; PL38 Noise-Induced Sensorineural Hearing
Loss; OT21
Non-Alcoholic Fatty Liver Disease; G35 Non-Articular Rheumatism; RH27 Non-Hodgkin Lymphoma; H46 Non-Melanoma Skin Cancers; D34 Non-Scarring Alopecia; D37
Non-Toxic Goitre; E29
Nonvascular Interventions; MI29 Normal Hearing Physiology; OT9 Normal Labour and Delivery; OB31 Normal Tension Glaucoma; OP26 Normocytic Anemia; H17
Nosocomial Infections; ID6 NSAID-Induced Ulceration; G13 Nuclear Medicine; MI25
Nummular Dermatitis; D15
Nutrition; FM6, P6
Nutritional Deficiencies; N17 Nutritional Status; G47
Nystagmus; N16
O
Obesity; A6, FM7, P11
Obsessive Compulsive Disorder; NS39 Obsessive-Compulsive Disorder; PS16 Obstetrical Anesthesia; A27 Obstetrical Complications; OB16 Obstetrical Hemorrhage; OB13 Obstructive Sleep Apnea; A6 Occupational Health; PH25
Ocular Drug Toxicity; OP41
Ocular Emergencies; OP5
Ocular Examination; OP5
Ocular Manifestations of Systemic
Disease; OP32
Ocular Pain; OP4
Ocular Trauma; OP40
Odynophagia; G5
Olecranon Fracture; OR19 Oligohydramnios; OB21 Omphalocele; GS63
Oncology; P44
Open Fractures; OR9
Operative Obstetrics; OB42 Operative Vaginal Delivery; OB42 Ophthalmia Neonatorum; OP39 Ophthalmologic Emergencies; ER42 Opioids; A25, A26, PS25
Opportunistic Fungi; ID34 Oppositional Defiant Disorder; PS39 Optic Disc Atrophy; N14
Optic Disc Edema; N14
Optics; OP7
Oral Ulcer; D5
Orbit; OP9
Orbital Cellulitis; OP9
Orbital Floor Fractures; PL33
Orchitis; U17
Organ Failure; R33
Orthopedic Emergencies; OR9 Orthopedic Injuries; ER15
Orthopedic X-Ray Imaging; OR8 Osgood-Schlatter Disease; OR45 Osteoarthritis; FM40, RH5 Osteomalacia; E43, MI24 Osteomyelitis; MI23, OR10, P85 Osteopenia; MI24
Osteoporosis; E41, FM41, MI24 Otalgia; ER39, OT6
Other Parkinsonian Disorders; N32 Otitis Externa; FM49, OT16
Otitis Media with Effusion; OT39, P50 Otoacoustic Emissions; OT12 Otosclerosis; OT18
Ottawa ankle and foot rules; ER17 Ottawa knee rules; ER16
Ottawa SAH Rule; ER23
Ovarian Tumours; GY40
Overactive Bladder; U12, U45 Overdose Patient; ER55
Oxygen Therapy; A10
P
Paget’s Disease of Bone; E44
Painful Diabetic Neuropathy; N43
Pain Management; A24
Pain Syndromes; N41
Palliative Care; GM11
Palpitations; C5
Pancreas; G3, G43, GS51, GS61 Pancreatic Cancer; GS52
Pancreatic Enzyme Abnormalities; G43 Pancreatitis; MI15
Pancytopenia; H8
Panic Disorder; PS14
Pap Test; GY43
Papulosquamous Diseases; D16 Paralytic Ileus; GS23
Paraneoplastic Syndrome; E49 Paraphilic Disorders; PS30
Parasitic Infections; D27, ID36 Parasitology; ID5
Parathyroid; GS60